Range
12.51 - 13.35
Vol / Avg.
1M/952.9K
Div / Yield
-
52 Wk
2.85 - 17.38
Mkt Cap
691.1M
Payout Ratio
-
Open
12.51
P/E
-
EPS
-3.28
Shares
54.1M
Outstanding
54.1M
Total Float
36.9M
load more
Sector: Health Care.Industry: Pharmaceuticals
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate isJeuveau, an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EOLSEvolus1.43%691.1M

Evolus Frequently Asked Questions

Q

How do I buy Evolus (EOLS) stock?

A

You can purchase shares of Evolus (NASDAQ: EOLS) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Evolus (EOLS) stock?

A

The latest price target for Evolus (NASDAQ: EOLS) was reported by Barclays on May 13, 2021. The analyst firm set a price target for 7.00 expecting EOLS to fall to within 12 months (a possible -45.18% downside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Evolus (EOLS)?

A

The stock price for Evolus (NASDAQ: EOLS) is $12.77 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Evolus (EOLS) pay a dividend?

A

There are no upcoming dividends for Evolus.

Q

When is Evolus (NASDAQ:EOLS) reporting earnings?

A

Evolus does not have any upcoming earnings scheduled.

Q

Is Evolus (EOLS) going to split?

A

There is no upcoming split for Evolus.

Q

What sector and industry does Evolus (EOLS) operate in?

A

Evolus is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.